skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist

Journal Article · · Nature Chemical Biology

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
NIHFOREIGN
OSTI ID:
1502205
Journal Information:
Nature Chemical Biology, Vol. 14, Issue 11; ISSN 1552-4450
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

References (51)

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy journal December 2009
Crystallizing Membrane Proteins for Structure Determination: Use of Lipidic Mesophases journal June 2009
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor journal January 2011
Protection against allergen-induced asthma by salmeterol journal December 1990
The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors: β-Adrenoceptor agonist selectivity journal March 2010
Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β 2-Adrenergic Receptors journal March 2015
Bioluminescence resonance energy transfer-based biosensors allow monitoring of ligand- and transducer-mediated GPCR conformational changes journal August 2018
Decay of an active GPCR: Conformational dynamics govern agonist rebinding and persistence of an active, yet empty, receptor state journal October 2016
Single-molecule analysis of ligand efficacy in β2AR–G-protein activation journal June 2017
Structural Insights into the Dynamic Process of β 2 -Adrenergic Receptor Signaling journal May 2015
Regulation of β 2 -Adrenergic Receptor Function by Conformationally Selective Single-Domain Intrabodies journal December 2013
Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo journal November 1991
GPCR Engineering Yields High-Resolution Structural Insights into  2-Adrenergic Receptor Function journal October 2007
Pathway and mechanism of drug binding to G-protein-coupled receptors journal July 2011
Long-Acting ??2 Agonists in the Management of Stable Chronic Obstructive Pulmonary Disease journal January 2000
β-Arrestin-biased Agonism at the β 2 -Adrenergic Receptor journal December 2007
Single-molecule FRET–derived model of the synaptotagmin 1–SNARE fusion complex journal February 2010
The Dynamic Process of β2-Adrenergic Receptor Activation journal January 2013
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody journal September 2013
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling journal August 2016
Synergistic Contributions of the Functional Groups of Epinephrine to Its Affinity and Efficacy at the β 2 Adrenergic Receptor journal April 2004
Identification of two distinct inactive conformations of the  2-adrenergic receptor reconciles structural and biochemical observations journal March 2009
Exosites: their current status, and their relevance to the duration of action of long-acting β2-adrenoceptor agonists journal September 1996
Salmeterol Stimulation Dissociates β 2 -Adrenergic Receptor Phosphorylation and Internalization journal February 2007
Salmeterol’s Extreme β 2 Selectivity Is Due to Residues in Both Extracellular Loops and Transmembrane Domains journal October 2014
Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. journal August 1996
N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor journal October 2012
β2-adrenoceptor agonists: current and future direction: β-agonists in asthma and COPD journal April 2011
Structure of a nanobody-stabilized active state of the β2 adrenoceptor journal January 2011
D RUG E FFICACY AT G P ROTEIN –C OUPLED R ECEPTORS journal April 2002
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex journal May 2009
Activation and allosteric modulation of a muscarinic acetylcholine receptor journal November 2013
The risk of asthma mortality with inhaled long acting  -agonists journal September 2008
Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma journal June 2014
Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET journal July 2016
Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding: MOLECULAR LOCALIZATION OF THE SALMETEROL EXOSITE WITHIN THE β journal September 1996
Crystal structure of the β2 adrenergic receptor–Gs protein complex journal July 2011
Propagation of conformational changes during μ-opioid receptor activation journal August 2015
Probing the Salmeterol Binding Site on the β 2 -Adrenergic Receptor Using a Novel Photoaffinity Ligand, [ 125 I]Iodoazidosalmeterol journal August 1999
Version 1.2 of the Crystallography and NMR system journal October 2007
Rational Design of Receptor Partial Agonists and Possible Mechanisms of Receptor Partial Activation: A Theory journal August 1996
Quantification of Ligand Bias for Clinically Relevant β 2 -Adrenergic Receptor Ligands: Implications for Drug Taxonomy journal December 2013
Allosteric regulation of G protein–coupled receptor activity by phospholipids journal November 2015
The pharmacology of salmeterol journal January 1993
A Close Look at Fluorescence Quenching of Organic Dyes by Tryptophan journal November 2005
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease journal February 2007
Cardiovascular Safety of Salmeterol in COPDa journal June 2003
Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the β 2 -Adrenergic Receptor Using Phosphoserine-Specific Antibodies journal January 2004
Characterization of Isoprenaline- and Salmeterol-Stimulated Interactions between β 2 -Adrenoceptors and β-Arrestin 2 Using β-Galactosidase Complementation in C2C12 Cells journal July 2005
Structure and function of an irreversible agonist-β2 adrenoceptor complex journal January 2011
Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry journal February 2017